{"product_id":"pa3-r","title":"PA3-R","description":"\u003cp\u003eA triple-agonist research peptide targeting GIP, GLP-1, and glucagon receptors. Available in 15mg and 30mg lyophilized vials, third-party tested at 98%+ purity.\u003c\/p\u003e\n\n\u003ch3\u003eWhat Is PA3-R?\u003c\/h3\u003e\n\u003cp\u003ePA3-R is research-grade retatrutide — a novel triple-agonist peptide that activates three distinct receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon. This tri-receptor mechanism distinguishes it from single and dual-agonist compounds currently under investigation. In Phase 2 clinical trials published in The New England Journal of Medicine, retatrutide demonstrated significant effects on metabolic parameters including body weight, glucose regulation, and lipid profiles.\u003c\/p\u003e\n\n\u003ch3\u003eHistory\u003c\/h3\u003e\n\u003cp\u003eRetatrutide was developed by Eli Lilly and Company and first entered clinical investigation in 2021. The compound emerged from research into multi-receptor agonism as an approach to metabolic disease, building on the success of dual-agonist compounds like tirzepatide. The Phase 2 trial results, published in 2023, generated significant interest in the research community due to the magnitude of metabolic effects observed with tri-receptor activation. Phase 3 trials are ongoing as of 2025.\u003c\/p\u003e\n\n\u003cp\u003eFor research purposes only. Not for human consumption.\u003c\/p\u003e\n","brand":"Protocol Aminos","offers":[{"title":"15MG","offer_id":44740617568301,"sku":null,"price":210.0,"currency_code":"COP","in_stock":true},{"title":"20MG","offer_id":44740617601069,"sku":null,"price":220.0,"currency_code":"COP","in_stock":true},{"title":"30MG","offer_id":44746867146797,"sku":null,"price":235.0,"currency_code":"COP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0744\/2232\/1197\/files\/Reta_2.png?v=1777503326","url":"https:\/\/protocolaminos.com\/products\/pa3-r","provider":"Protocol Aminos","version":"1.0","type":"link"}